Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Current Liabilities -----

What is the latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2021-

How is Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2021 - -

Compare Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,453.1 Cr 0.8% 4.9% 28% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.8%

4.9%

28%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses